AriBio Co., Ltd. announced that it will issue 412,962 common shares at an issue price of KRW 27,000 per share for gross proceeds of KRW 11,149,974,000 on January 18, 2024. The transaction will include participation from new investor, Solux Co., Ltd. The transaction has been approved by the board of directors. The company is expected to close the transaction on February 2, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,080 KRW | -3.40% | +0.08% | -34.84% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.84% | 283M | |
-1.40% | 1.28B | |
-10.28% | 1.12B | |
-14.59% | 1.06B | |
-4.55% | 1B | |
+5.53% | 896M | |
+0.61% | 611M | |
-32.60% | 581M | |
-13.63% | 495M | |
-20.60% | 398M |
- Stock Market
- Equities
- A290690 Stock
- News Solux Co., Ltd
- AriBio Co., Ltd. announced that it expects to receive KRW 11.149974 billion in funding from Solux Co., Ltd